£73.14

It has never been this cheap. We have no record of a lower price.

£73 today · cheaper than every other day in the last 3 months

Springer Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 71 days · 71 data points (no recent data)

Historical
Generating forecast…
£73.14 £69.48 £70.95 £72.41 £73.87 £75.33 £76.80 11 August 2026 28 August 2026 15 September 2026 02 October 2026 20 October 2026
View at Amazon ↗

Price data last checked 20 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price
71 days 0 18 36 53 71 £73 Days at Price

Price Analysis

Most common price: £73 (71 days, 100.0%)

Price range: £73 - £73

Price levels: 1 different prices over 71 days

Description

This book discusses the latest developments in Poly (ADP-ribose) polymerase (PARP) inhibitor drug development. It focuses on the translational and clinical development of the latest drugs, as well as the evidence for regulatory approval of PARP inhibitors in multiple different molecular subtypes and tumor indications. The most-up-to-date information on basic scientific research on DNA repair pathways and the DNA Damage Response (DDR) is also covered. Every chapter contains insight into the preclinical, translational along with clinical aspects of a specific DDR inhibitor with key and expert opinion points reinforcing the most important concepts detailed to enable the reader to develop a deep understanding of the topic. Targeting the DNA Damage Response for Cancer Therapy comprehensively reviews the application of PARP and other DDR inhibitors across oncology disciplines. Therefore, it is a valuable resource for all medical professionals and researchers who use or who are researching the use of these inhibitors on a day-to-day basis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 November 2024
Listed Since
19 November 2024

Barcode

No barcode data available

Similar Products You Might Like

Cancer Stem Cells and Cancer Therapy (Stem Cell Biology and Regenerative Medicine, 76)
90% match

Cancer Stem Cells and Cancer Therapy (Stem Cell Biology and Regenerative Medicine, 76)

Springer

£166.57 26 Aug 2026
Cancer Treatment: An Interdisciplinary Approach: 2 (Interdisciplinary Cancer Research, 2)
89% match

Cancer Treatment: An Interdisciplinary Approach: 2 (Interdisciplinary Cancer Research, 2)

Springer

£120.00 22 Oct 2026
Cancer Metabolism: Molecular Mechanisms and Therapeutic Strategies (Cancer Treatment and Research, 195)
89% match

Cancer Metabolism: Molecular Mechanisms and Therapeutic Strategies (Cancer Treatment and Research, 195)

Springer

£88.21 10 Sep 2026
Molecular Precision Medicine in Cancer (Cancer Drug Discovery and Development)
89% match

Molecular Precision Medicine in Cancer (Cancer Drug Discovery and Development)

Springer

£166.80 27 Aug 2026
Onco-critical Care: An Evidence-based Approach
89% match

Onco-critical Care: An Evidence-based Approach

Springer

£74.21 21 Oct 2026
Squamous cell Carcinoma: Molecular Therapeutic Targets
89% match

Squamous cell Carcinoma: Molecular Therapeutic Targets

Springer

£111.44 22 Oct 2026
Cancer Research Guidance for Clinicians and Researchers
89% match

Cancer Research Guidance for Clinicians and Researchers

Springer

£130.71 09 Nov 2026
Image-Guided Interventions in Oncology: An Interdisciplinary Approach
89% match

Image-Guided Interventions in Oncology: An Interdisciplinary Approach

Springer

£65.05 27 Oct 2026
Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment
88% match

Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment

Springer

£72.37 26 Oct 2026
Herbs for Cancer Treatment
88% match

Herbs for Cancer Treatment

Springer

£156.36 21 Oct 2026
Nano Drug Delivery for Cancer Therapy: Principles and Practices
88% match

Nano Drug Delivery for Cancer Therapy: Principles and Practices

Springer

£135.49 21 Oct 2026
Methods in Cancer Stem Cell Biology
88% match

Methods in Cancer Stem Cell Biology

Springer

£100.11 26 Oct 2026
Cancer Drug Discovery: Science and History
88% match

Cancer Drug Discovery: Science and History

Springer

£112.48 25 Oct 2026
Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
88% match

Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates

Springer

£141.86 20 Oct 2026
Cytokine and Chemokine Networks in Cancer
88% match

Cytokine and Chemokine Networks in Cancer

Springer

£142.07 22 Oct 2026
Understanding End of Life Practices: Perspectives on Communication, Religion and Culture: 187 (Cancer Treatment and Research, 187)
88% match

Understanding End of Life Practices: Perspectives on Communication, Religion and Culture: 187 (Cancer Treatment and Research, 187)

Springer

£73.14 24 Oct 2026
Frontiers of Biostatistical Methods and Applications in Clinical Oncology
88% match

Frontiers of Biostatistical Methods and Applications in Clinical Oncology

Springer

£84.32 24 Oct 2026
Urogenital Cancers: An Interdisciplinary Approach: 16 (Interdisciplinary Cancer Research, 16)
88% match

Urogenital Cancers: An Interdisciplinary Approach: 16 (Interdisciplinary Cancer Research, 16)

Springer

£147.11 27 Aug 2026
Pathology and Epidemiology of Cancer
88% match

Pathology and Epidemiology of Cancer

Springer

£125.78 22 Oct 2026
Therapeutic potential of Cell Cycle Kinases in Breast Cancer
87% match

Therapeutic potential of Cell Cycle Kinases in Breast Cancer

Springer

£142.07 26 Oct 2026
Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer
87% match

Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer

Springer

£100.11 27 Oct 2026
RNA Damage and Repair
87% match

RNA Damage and Repair

Springer

£120.94 21 Oct 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
87% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 21 Oct 2026
Rectal Cancer: Modern Approaches to Treatment
87% match

Rectal Cancer: Modern Approaches to Treatment

Springer

£62.91 24 Oct 2026